Cargando…
Clinical Relevance of the serum CTLA-4 in Cats with Mammary Carcinoma
Cytotoxic T lymphocyte associated antigen 4 (CTLA-4) serves an important role in breast cancer progression, which has led to the development of novel immunotherapies aimed at blocking tumor immune evasion. Although feline mammary carcinoma is increasingly recognized as a valuable cancer model, no st...
Autores principales: | Urbano, Ana Catarina, Nascimento, Catarina, Soares, Maria, Correia, Jorge, Ferreira, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052166/ https://www.ncbi.nlm.nih.gov/pubmed/32123292 http://dx.doi.org/10.1038/s41598-020-60860-3 |
Ejemplares similares
-
Anaplastic Mammary Carcinoma in Cat
por: Soares, Maria, et al.
Publicado: (2021) -
Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes
por: Gameiro, Andreia, et al.
Publicado: (2021) -
Serum PD-1/PD-L1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma Subtypes
por: Nascimento, Catarina, et al.
Publicado: (2020) -
TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma
por: Valente, Sofia, et al.
Publicado: (2023) -
Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma
por: Gameiro, Andreia, et al.
Publicado: (2021)